Home/Filings/4/0001104659-24-125527
4//SEC Filing

Pawar Neal 4

Accession 0001104659-24-125527

CIK 0001868912other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:15 PM ET

Size

7.2 KB

Accession

0001104659-24-125527

Insider Transaction Report

Form 4
Period: 2024-12-02
Pawar Neal
Chief Operating Officer
Transactions
  • Sale

    Class A Common Stock

    2024-12-02$10.03/sh21,801$218,6641,143,544 total
  • Sale

    Class A Common Stock

    2024-12-03$10.09/sh26,246$264,8221,117,298 total
Footnotes (3)
  • [F1]Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares and does not represent discretionary trades by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.94 to $10.12. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.19. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.

Issuer

Enfusion, Inc.

CIK 0001868912

Entity typeother

Related Parties

1
  • filerCIK 0002000632

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:15 PM ET
Size
7.2 KB